02/16/2024
6:01 AM | Ironwood Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
6:04 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:01 PM | Ironwood Pharmaceuticals (Issuer)
John Minardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:50 PM | Ironwood Pharmaceuticals (Issuer)
Silver Ronald (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:53 PM | Ironwood Pharmaceuticals (Issuer)
Shetzline Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:35 PM | Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
7:39 PM | Emany Sravan Kumar (Reporting)
Ironwood Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/14/2024
7:42 PM | Davis Andrew (Reporting)
Ironwood Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
2:12 PM | Ironwood Pharmaceuticals (Subject)
LSV ASSET MANAGEMENT (Filed by)
| Form SC 13G/A | |
01/25/2024
8:21 AM | Ironwood Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/22/2024
1:03 PM | BlackRock Inc. (Filed by)
Ironwood Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/19/2024
3:05 PM | Emany Sravan Kumar (Reporting)
Ironwood Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:05 PM | Ironwood Pharmaceuticals (Issuer)
John Minardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:05 PM | Ironwood Pharmaceuticals (Issuer)
Shetzline Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
3:05 PM | Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2024
9:16 AM | Ironwood Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
01/08/2024
5:05 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/14/2023
3:26 PM | Ironwood Pharmaceuticals (Subject)
Kessler Marla L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023
6:07 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2023
4:07 PM | Emany Sravan Kumar (Reporting)
Ironwood Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
3:30 PM | Ironwood Pharmaceuticals (Filer)
| Form 8-K/A | |
08/16/2023
3:20 PM | Ironwood Pharmaceuticals (Issuer)
John Minardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
3:21 PM | Ironwood Pharmaceuticals (Issuer)
Silver Ronald (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/11/2023
3:02 PM | Ironwood Pharmaceuticals (Subject)
John Minardo (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2023
6:08 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2023
4:36 PM | Ironwood Pharmaceuticals (Subject)
Rickard Jason (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/07/2023
3:21 PM | Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
| Form SC 13D | |
07/05/2023
11:01 AM | Ironwood Pharmaceuticals (Subject)
WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
| Form SC 13G/A | |
06/29/2023
7:32 AM | Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
| Form SC TO-T/A | |
06/26/2023
3:08 PM | Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
| Form SC TO-T/A | |
06/22/2023
4:26 PM | Currie Mark G (Reporting)
Ironwood Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
4:26 PM | DENNER ALEXANDER J (Reporting)
Ironwood Pharmaceuticals (Issuer)
Sarissa Capital Management LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
4:27 PM | Dreyfus Andrew (Reporting)
Ironwood Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
4:28 PM | Duane Jon R (Reporting)
Ironwood Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
4:29 PM | Ironwood Pharmaceuticals (Issuer)
Kessler Marla L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
4:29 PM | Ironwood Pharmaceuticals (Issuer)
McHugh Julie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
4:30 PM | Ironwood Pharmaceuticals (Issuer)
Moukheibir Catherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
4:31 PM | Ironwood Pharmaceuticals (Issuer)
Shepard Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:08 PM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2023
3:05 PM | DENNER ALEXANDER J (Reporting)
Ironwood Pharmaceuticals (Issuer)
Sarissa Capital Management LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:05 PM | Ironwood Pharmaceuticals (Issuer)
Moukheibir Catherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
New crypto project uncovers 2,050% in 65 days (Ad) During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price.
I believe it will be the best performing crypto of 2024. Just click here to sign up and be among the first to get it. |
06/20/2023
6:30 AM | Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
| Form SC TO-T/A | |
06/16/2023
6:09 AM | Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
| Form SC TO-T/A | |
06/07/2023
5:08 PM | Ironwood Pharmaceuticals (Subject)
Rickard Jason (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/01/2023
4:45 PM | Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2023
5:46 AM | Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
| Form SC TO-T | |
05/24/2023
3:05 PM | Ironwood Pharmaceuticals (Issuer)
MCCOURT Thomas A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
3:05 PM | Davis Andrew (Reporting)
Ironwood Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
3:05 PM | Ironwood Pharmaceuticals (Issuer)
Shetzline Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2023
4:26 PM | Ironwood Pharmaceuticals (Filed by)
VectivBio Holding AG (Subject)
| Form SC TO-C | |
05/22/2023
3:25 PM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2023
4:39 PM | Ironwood Pharmaceuticals (Subject)
MCCOURT Thomas A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/19/2023
4:25 PM | Davis Andrew (Reporting)
Ironwood Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/10/2023
7:54 AM | Ironwood Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
05/08/2023
1:53 PM | Ironwood Pharmaceuticals (Subject)
MCCOURT Thomas A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/04/2023
3:05 PM | Ironwood Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023
6:12 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
